However extensive use of antibiotics and zinc oxide in intensive animal production is 20 unwanted as it may promote microbial antibiotic resistance and pose environmental 21 problems. Recently, in an experimental model of PWD, we observed that oral 22 administration of purified porcine immunoglobulin G (ppIgG) from pooled natural pig 23 plasma could reduce enteric infection. In the present study we were able to reproduce 24 these results as it was observed that oral ppIgG accelerated clearance of faecal 25 haemolytic bacteria in pigs challenged with E. coli in comparison with pigs not receiving 26 ppIgG. This effect was observed upon feeding ppIgG for seven days postweaning 27 suggesting that ppIgG does not have to be used prophylactically for several days 28 preweaning. Furthermore, the effect of oral administration of ppIgG for seven days 29 postweaning was equal to or better than that of dietary zinc oxide in reducing diarrhoea 30 symptoms and in clearing faecal haemolytic bacteria for 14 days postweaning. These 31 observations warrant future trials of dietary ppIgG in intensive swine production units to 32 establish its performance as an alternative to dietary antibiotics and zinc oxide for 33 preventing PWD. 34
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Postweaning diarrhoea; Immunoglobulins; IgG; Zinc oxide; Antibiotics; ETEC; E. coli F4; 36 Feed supplement; Feacal score 37 38 1. Introduction 39 After parturition, lactogenic immunity provides offspring with oro-gastric protection 40 against infectious pathogens (Hedegaard and Heegaard, 2016) . In the conventional 41 swine production systems piglets are weaned at an immunologically immature age (3-4 weeks) depriving them of the continued supply of protective lactogenic antibodies at the 43 same time as they are placed in a new environment with increased risk of enteric 44 bacterial infections that may lead to postweaning diarrhoea (PWD) (Madec et al., 1998) . 45 PWD is characterised by diarrhoea caused by enteric infection by Enterotoxigenic 46 Escherichia coli (ETEC) usually within three days postweaning ( Fairbrother et al., 2005) . 47 PWD, like other enteric infections in pigs, can be treated with dietary antibiotics 48 (primarily tetracyclines, penicillins and macrolides ( Becker, 2010; DANMAP, 2015 ; 49 Wageningen University, 2012)), and/or zinc oxide (Pluske, 2013) . Indeed, antibiotics and 50 zinc can improve average daily growth (ADG) in weaner piglets ( Cromwell, 2002 ; Molist 51 et al., 2011) , and dietary zinc can reduce frequency of PWD in weaner piglets ( Owusu-52 Asiedu et al., 2003 ; Pluske, 2013) . The mechanisms by which zinc oxide increases ADG 53 and reduces diarrhoea in weaner piglets are not fully understood but seem to involve 54 both restoring plasma zinc levels to normal in piglets after weaning (Davin et al., 2013) 55 and improving intestinal homeostasis ( Liu et al., 2014a; Liu et al., 2014b ; Shen et al., 56 2014) . 57 However, the widespread use of dietary zinc oxide in intensive animal production can 58 result in pollution of farmlands and groundwater through repeated fertilisation with 59 zinc-containing residual manure (Hill et al., 2005) . In addition, zinc oxide in combination 60 with antibiotics appears to accelerate microbial antibiotic resistance by increasing the 61 rate of the exchange of antibiotic-resistance-gene containing plasmids in the microbiota 62 community in both soil and piglet intestines (Lin et al., 2016; Pal et al., 2015 ; Vahjen et 63 al., 2015) ; thus, there is a need to reduce both kinds of interventions. 64
As a sustainable and economically feasible alternative to antibiotics and zinc for treating 65 PWD, we have previously investigated the use of natural purified porcine 66 immunoglobulin G (ppIgG) from pooled abattoir blood plasma (Hedegaard et al., 2016) . 67
First, it was established that natural ppIgG does indeed contain immunoglobulin 68 dependent anti-E. coli activity. Secondly it was shown that a dietary ppIgG supplement 69 in a model of PWD led to faster clearance of an ETEC challenge infection than seen in a 70 comparable control group not provided with dietary ppIgG ( Hedegaard et al., 2016) . 71
This prompted us to further investigate this effect of ppIgG in E.coli challenge models. A 72 long term, low ppIgG dose experiment and a short term, high ppIgG dose experiment 73 were performed. In both experiments dietary ppIgG resulted in reduction of diarrhoea 74 and in number of faecal haemolytic bacteria; moreover, in the second trial we observed 75 that ppIgG reduced diarrhoea and cleared the enteric infection faster than dietary zinc 76 oxide. These observations warrant future experiments investigating the use of dietary 77 ppIgG postweaning as an alternative to dietary zinc oxide and antibiotics in 78 treating/preventing PWD. 79 80
Materials & methods 81
The study comprised two infection experiments, both using E. coli O149 challenge at 82 two consecutive days post weaning. In experiment 1 (long term, low IgG dose pilot 83 study) 750 mg/day of ppIgG was provided orally for five days before and 10 days post 84 weaning. In experiment 2 (short term, high IgG dose) 1.9 g of ppIgG was given orally 85 twice daily for seven days after weaning/challenge. Experiment 2 also comprised a 86 group receiving dietary zinc oxide for 10 days after weaning. 87 88 2.1. Purified porcine immunoglobulin G (ppIgG)
The ppIgG was prepared from pooled pig plasma by expanded bed chromatography 90 (EBA) at Upfront Chromatography A/S (Copenhagen), as described previously 91 (Hedegaard et al., 2016) . Concentrated porcine blood plasma was obtained from Daka 92 SARVAL A/S (Lunderskov, Denmark). The batch of ppIgG used in first experiment 93 (experiment 1, see below) was the same as in (Hedegaard et al., 2016) , whereas a new 94 batch of ppIgG was prepared prior to the second (experiment 2, see below). 95 Using the antigen specific ELISA it was found that the ppIgG batch used in experiment 1 120 had lost 14% of activity in comparison to the original plasma pool, whereas the batch 121 used in experiment 2 had lost no activity (data not shown In the first experiment, half of the piglets (Table 1 ; Exp. 1, Group 1 + 2) received once 135 daily for 15 days (5 days preweaning and 10 days postweaning) 20 ml (750 mg) of ppIgG, provided by a 20 ml syringe; a small plastic tube was connected to the syringe and the 137 ppIgG was slowly dipped in and piglets willingly lapped up, ensuring that no ppIgG was 138 lost. 139
The other half of the pigs received 20 ml 0.9% NaCl (Table 1 ; Exp. 1, Group 3 + 4). Pigs 140 were provided the immunoglobulin product before feeding. 141
In the second experiment, pigs were allotted into three challenge-groups (Table 1 ; lower 142 part): two groups received no immunoglobulins but piglets were provided with 25 ml of 143 0.9% NaCl and provision of feed (from day of weaning) based on wheat, barley and 144 dehulled soybean, and with either 2500 ppm zinc oxide (Hammershøj Pharmacy, 145 Hammershøj, Denmark) for 14 days postweaning (Table 1 ; Exp. 2, Group 1), or no zinc 146 oxide (Table 1 ; Exp. 2, Group 2). The third group received ppIgG via 20 ml syringe on the 147 morning before weaning (day 27), and on the morning of weaning (day 28). The ppIgG 148 feeding was continued twice daily by drench gun for 7 days postweaning with a 149 provision of 25 ml (1.9 g) of ppIgG twice daily (Table 1; In both experiments, pigs were orally inoculated with 1.0 × 109 colony-forming units 175 (cfu) of E. coli O149:F4 in 5 ml 0.9% NaCl on day 1 and 2 after weaning (day 0 was the 176 day of weaning) using a syringe. After inoculation, the tube was flushed with 177 approximately 10 ml 10% NaHCO3 in order to neutralize gastric acid and increase the 178 survival rate of the challenge strain in the stomach, and to ascertain that all the E. coli 179 suspension had been given to the piglets. The control pigs (exp. 1) received equivalent 180 amounts (approximately 5 ml) of 0.9% NaCl and 10 ml 10% NaHCO3 in order to obtain an equal level of stress associated with the oral inoculation as for the challenge 182 treatment. 183 184 2.3.3. Performance and diarrhoea assessment 185
Diarrhoea assessment was based on the consistency of the faeces (1 = hard, dry and 186 cloddy, 2 = firm, 3 = soft with shape, 4 = soft and liquid, 5 = watery and dark, 6 = watery 187 and yellow, 7 = foamy and yellow) from the day prior to challenge until 7 days after. A 188 faecal consistency score >3 was defined as a clinical sign of diarrhoea (Carstensen et al., 189 2005) . Before the E. coli challenge, and on day 2 after challenge, and daily until day 5 190 after challenge, and thereafter every second day during the second week after weaning, 191 faecal samples were collected from the rectum of the pigs and 1 g faeces was suspended 192 in a (1:10, wt/wt) peptone solution and homogenized by bag mixer (BagMixer100, 193 Interscience, St. Nom, France). Serial dilutions of the slurry were done prior to 194 enumeration of haemolytic E. coli on blood agar (BA; Oxoid) after aerobic incubation at 195 37 °C overnight. From each BA plate, five haemolytic E. coli colonies were selected and 196 tested for O149 and O138 type reactions by O-seroagglutination (Statens Serum Institut, 197 Copenhagen, Denmark). In addition, faecal samples were analysed for dry matter by 198 freeze-drying (ScanVac Coolsafe 55, Labogene Aps, Lynge, Denmark). 199
Feed intake was recorded daily for each pen and body weight of the pigs was recorded 200 at the beginning and weekly thereafter until the end of the experiment. Average daily 201 feed intake (ADFI) and gain (ADG) were determined based on pen by dividing the total 202 feed intake or total weight gain of pigs in each pen by days of feeding. 
Results and discussion 212
In this study we performed two infection experiments using an E. coli O149 challenge 213 strain at both day one and two after weaning. The administration of ppIgG was different 214 in the two experiments: In experiment 1, 750 mg of ppIgG was provided orally once daily 215 prophylactically for five days preweaning and then 10 days postweaning, whereas in 216 experiment 2, 1.9 g of ppIgG was administered orally twice daily for seven days 217 postweaning. Two different ppIgG batches were used for the two experiments, for 218 experiment 1 a 37.5 mg/ml batch and for experiment 2 a 75 mg/ml batch. 219 220
Disease 221
In both experiments diarrhoea was observed within one day after inoculation due to the 222 O149 ETEC challenge as observed by faecal scoring (Fig. 1A + B ) and faecal dry matter 223 measurement (Fig. 1C + D) . We observed in both experiments that the +ppIgG 224 +challenge group (group 2 in exp. 1 and group 3 in exp. 2) had, at day five, significantly 225 less diarrhoea as compared to the control challenge groups (group 4 in exp. 1 and group 226 2 in exp. 2) that were not provided with ppIgG as observed by a lower faecal scoring and 227 a higher percentage of faecal dry matter (p < 0.03; Fig. 1, days 1-5 ). In experiment 1 the 228 O149 ETEC challenge strain began to cease at day 7, however an unintended enteral 229 infection, starting around day 5-7 after weaning and lasting the remainder of the study 230 period was observed ( Fig. 1A + C, days 5-21) , coinciding with the appearance of an O138 231 ETEC strain in faeces (detected by PCR; data not shown). The presence of this 232 unintended infection somewhat obscured experiment 1, however the data from day 0 to 233 five were promising and prompted us to conduct a second experiment in which the daily 234
IgG dose was quadrupled but then only provided seven days post weaning. This batch of 235 ppIgG had an IgG concentration of 75 mg/ml, and was administered twice daily, 236 amounting to a daily dose of 3.8 g. 237 Experiment 2 proceeded without any unintended infection, and group 3 (+ppIgG 238 +challenge group) had significantly less diarrhoea than both group 1 and 2 (+zinc 239 +challenge and no treatment groups) within the first week after weaning (p < 0.02 Two-240 way ANOVA; Fig. 1B + D) ; demonstrating that ppIgG significantly reduced diarrhoea in 241 the PWD model within the first week post weaning to the same level or lower than 242 dietary zinc. 243
Moreover, our results indicate that it is not necessary to use ppIgG prophylactically for 244 several days preweaning as there was a clear effect of ppIgG in experiment 2 on 245 diarrhoea without the five days preweaning ppIgG treatment applied in experiment 1 246 ( Fig. 1) . This also corroborates a previous study (Hedegaard et al., 2016) where ppIgG 247 was mixed into the feed that was only available from weaning and decreased 248 diarrhoeagenic Enterobacteriaceae in comparison to a non-ppIgG diet. Also, it has been 249
shown (Foged et al., 1986 ) that monoclonal anti-E. coli F4 fimbriae antibodies 250 administered at as well as after challenge, but not prophylactically, protected neonatal 251 piglets from an otherwise lethal challenge with F4+ ETEC. On the other hand, it seems to 252 be important to maintain a high administration frequency and an adequately high 253 antibody dose for limiting diarrhoea. 254 255
Microbiology 256
In both experiments ppIgG helped clear the challenge strain within one week of 257 challenge (Fig. 2, days 1-7 ). However, as noted above, all groups in experiment 1 258 experienced an unintended O138 ETEC infection from day 4-9, as seen by an increase in 259 numbers of faecal haemolytic bacteria ( Fig. 2A , days 4 + 7 + 9). Group 1 (+ppIgG no 260 challenge) experienced this infection at day 4 while it was observed in group 2 (+ppIgG 261 +challenge) on day 9. Thus, the daily administration of 750 mg of natural IgGs did not 262 provide protection against the unintended infection in neither of the two +ppIgG groups 263 ( Fig. 2A , groups 1 + 2, days 4-21), even though in vitro data support that ppIgG binds to 264 O138 (and O149) ETEC and can inhibit their adhesion to intestinal epithelial cells in vitro 265 ( Hedegaard et al., 2016) . This might indicate that the unintended infection was 266 multifactorial, and/or that the daily dose of 750 mg natural ppIgG used in this 267 experiment was not adequate to prevent this type of infection. Data from dose-268 response field trials are needed before any further conclusions can be made on this 269 matter. 270
In experiment 2, only infection with the challenge-strain was observed. Confirming 271 previous results (Hedegaard et al., 2016) , ppIgG caused a faster clearance of 272 diarrhoeagenic (haemolytic) bacteria in group 3 than was observed in the other two 273 groups (Fig. 2B ). Thus day 7 was the last day on which faecal haemolytic bacteria were detected in group 3 (+ppIgG), while these bacteria could still be detected on day 9 in 275 group 1 (+zinc group), and in group 2 (control) one piglet still had faecal haemolytic 276 bacteria on day 15 (Fig. 2B) . Taken together, ppIgG appears to intervene with the 277 colonization by the ETEC challenge strain shortening the period of infection significantly 278 ( Fig. 2B , Day 5, p < 0.02) and was as efficient as dietary zinc in reducing the infection 279 with the ETEC challenge strain. Although this suggests that ppIgG can shorten the 280 duration of diarrhoea in weaner piglets by decreasing the number of faecal 281 diarrhoeagenic haemolytic bacteria, this should ideally take place without a perturbing 282 the composition of the normal intestinal microbiota. In experiment 1, no change in the 283 faecal non-haemolytic bacteria were initially observed (Fig. 2C , days 1-5) however, as 284 the unintended infection emerged the number of faecal non-haemolytic bacteria began 285 decreasing (Fig. 2C, days 7-21) . In group 2 (+ppIgG +challenge) the faecal non-286 haemolytic bacteria actually were not recovered for 3 days at the height of the 287 unintended infection (Fig. 2C, days 11-14 Disease (diarrhoea) frequency, growth and feed conversion are primary end points for 296 swine producers however the two experiments described here comprised low numbers 297 of piglets (n = 12/18) and pens (n = 4/3) making it very difficult to analyse growth data 298 statistically. Also, the data on growth and feed intake showed a very large pig-to-pig 299 variation. For example, in experiment 2 half of the piglets in group 3 (+ppIgG), for 300 unknown reasons, became anorexic during the third week resulting in almost no weight 301 gain for the group. Therefore it will be interesting to observe how ppIgG 302 supplementation will influence disease resistance, growth and feed conversion in field 303 trials incorporating an adequate number of pigs to allow for appropriate statistical data 304 analysis to be performed. In spite of being a small preliminary study the results shown 305 here do however demonstrate the ability of dietary ppIgG to clear an enteric ETEC 306 infection and thus ppIgG could be used as an alternative to dietary zinc. 
